1<html xmlns:v="urn:schemas-microsoft-com:vml" 2xmlns:o="urn:schemas-microsoft-com:office:office" 3xmlns:w="urn:schemas-microsoft-com:office:word" 4xmlns:st1="urn:schemas-microsoft-com:office:smarttags" 5xmlns="http://www.w3.org/TR/REC-html40"> 6 7<head> 8<meta http-equiv=Content-Type content="text/html; charset=iso-8859-1"> 9<meta name=ProgId content=Word.Document> 10<meta name=Generator content="Microsoft Word 11"> 11<meta name=Originator content="Microsoft Word 11"> 12<link rel=File-List href="index_files/filelist.xml"> 13<link rel=Edit-Time-Data href="index_files/editdata.mso"> 14<!--[if !mso]> 15<style> 16v\:* {behavior:url(#default#VML);} 17o\:* {behavior:url(#default#VML);} 18w\:* {behavior:url(#default#VML);} 19.shape {behavior:url(#default#VML);} 20</style> 21<![endif]--> 22<title>MERLINQ - Nanorobot pioneer reveals status of simulator, stem cell work</title> 23<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" 24 name="State"/> 25<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" 26 name="City"/> 27<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" 28 name="country-region"/> 29<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" 30 name="place"/> 31<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" 32 name="PlaceName"/> 33<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" 34 name="PlaceType"/> 35<!--[if gte mso 9]><xml> 36 <o:DocumentProperties> 37 <o:Author>Adriano</o:Author> 38 <o:LastAuthor>Adriano</o:LastAuthor> 39 <o:Revision>25</o:Revision> 40 <o:TotalTime>10</o:TotalTime> 41 <o:Created>2008-05-16T18:36:00Z</o:Created> 42 <o:LastSaved>2008-05-16T19:56:00Z</o:LastSaved> 43 <o:Pages>3</o:Pages> 44 <o:Words>3617</o:Words> 45 <o:Characters>20620</o:Characters> 46 <o:Company>Monash University</o:Company> 47 <o:Lines>171</o:Lines> 48 <o:Paragraphs>48</o:Paragraphs> 49 <o:CharactersWithSpaces>24189</o:CharactersWithSpaces> 50 <o:Version>11.8122</o:Version> 51 </o:DocumentProperties> 52</xml><![endif]--><!--[if gte mso 9]><xml> 53 <w:WordDocument> 54 <w:Zoom>155</w:Zoom> 55 <w:SpellingState>Clean</w:SpellingState> 56 <w:GrammarState>Clean</w:GrammarState> 57 <w:FormsDesign/> 58 <w:ValidateAgainstSchemas/> 59 <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> 60 <w:IgnoreMixedContent>false</w:IgnoreMixedContent> 61 <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> 62 <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel> 63 </w:WordDocument> 64</xml><![endif]--><!--[if gte mso 9]><xml> 65 <w:LatentStyles DefLockedState="false" LatentStyleCount="156"> 66 </w:LatentStyles> 67</xml><![endif]--><!--[if !mso]><object 68 classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></object> 69<style> 70st1\:*{behavior:url(#ieooui) } 71</style> 72<![endif]--> 73<link rel=Stylesheet type="text/css" media=all 74href="index_files/template_css.css"> 75<link rel=Stylesheet type="text/css" media=all 76href="index_files/css_color_blue.css"> 77<style> 78<!-- 79 /* Font Definitions */ 80 @font-face 81 {font-family:Wingdings; 82 panose-1:5 0 0 0 0 0 0 0 0 0; 83 mso-font-charset:2; 84 mso-generic-font-family:auto; 85 mso-font-pitch:variable; 86 mso-font-signature:0 268435456 0 0 -2147483648 0;} 87@font-face 88 {font-family:Verdana; 89 panose-1:2 11 6 4 3 5 4 4 2 4; 90 mso-font-charset:0; 91 mso-generic-font-family:swiss; 92 mso-font-pitch:variable; 93 mso-font-signature:536871559 0 0 0 415 0;} 94@font-face 95 {font-family:"Trebuchet MS"; 96 panose-1:2 11 6 3 2 2 2 2 2 4; 97 mso-font-charset:0; 98 mso-generic-font-family:swiss; 99 mso-font-pitch:variable; 100 mso-font-signature:647 0 0 0 159 0;} 101@font-face 102 {font-family:Times; 103 panose-1:2 2 6 3 5 4 5 2 3 4; 104 mso-font-charset:0; 105 mso-generic-font-family:roman; 106 mso-font-pitch:variable; 107 mso-font-signature:536902279 -2147483648 8 0 511 0;} 108 /* Style Definitions */ 109 p.MsoNormal, li.MsoNormal, div.MsoNormal 110 {mso-style-parent:""; 111 margin:0cm; 112 margin-bottom:.0001pt; 113 mso-pagination:widow-orphan; 114 font-size:12.0pt; 115 font-family:"Times New Roman"; 116 mso-fareast-font-family:"Times New Roman";} 117h3 118 {mso-margin-top-alt:auto; 119 margin-right:0cm; 120 mso-margin-bottom-alt:auto; 121 margin-left:0cm; 122 mso-pagination:widow-orphan; 123 mso-outline-level:3; 124 font-size:13.5pt; 125 font-family:"Times New Roman"; 126 font-weight:bold;} 127a:link, span.MsoHyperlink 128 {color:#002E61; 129 mso-text-animation:none; 130 border:none windowtext 1.0pt; 131 mso-border-alt:none windowtext 0cm; 132 padding:0cm; 133 font-weight:bold; 134 text-decoration:none; 135 text-underline:none; 136 text-decoration:none; 137 text-line-through:none;}
138a:visited, span.MsoHyperlinkFollowed 139 {color:#002E61; 140 mso-text-animation:none; 141 border:none windowtext 1.0pt; 142 mso-border-alt:none windowtext 0cm; 143 padding:0cm; 144 font-weight:bold; 145 text-decoration:none; 146 text-underline:none; 147 text-decoration:none; 148 text-line-through:none;} 149p 150 {mso-margin-top-alt:auto; 151 margin-right:0cm; 152 mso-margin-bottom-alt:auto; 153 margin-left:0cm; 154 mso-pagination:widow-orphan; 155 font-size:12.0pt; 156 font-family:"Times New Roman"; 157 mso-fareast-font-family:"Times New Roman";} 158p.clr, li.clr, div.clr 159 {mso-style-name:clr; 160 mso-margin-top-alt:auto; 161 margin-right:0cm; 162 mso-margin-bottom-alt:auto; 163 margin-left:0cm; 164 mso-pagination:widow-orphan; 165 font-size:12.0pt; 166 font-family:"Times New Roman"; 167 mso-fareast-font-family:"Times New Roman";} 168p.content, li.content, div.content 169 {mso-style-name:content; 170 mso-margin-top-alt:auto; 171 margin-right:0cm; 172 mso-margin-bottom-alt:auto; 173 margin-left:0cm; 174 line-height:13.5pt; 175 mso-pagination:widow-orphan; 176 font-size:7.5pt; 177 font-family:"Times New Roman"; 178 mso-fareast-font-family:"Times New Roman";} 179p.pathway, li.pathway, div.pathway 180 {mso-style-name:pathway; 181 mso-margin-top-alt:auto; 182 margin-right:0cm; 183 mso-margin-bottom-alt:auto; 184 margin-left:0cm; 185 mso-pagination:widow-orphan; 186 font-size:7.5pt; 187 font-family:"Times New Roman"; 188 mso-fareast-font-family:"Times New Roman";} 189p.small, li.small, div.small 190 {mso-style-name:small; 191 mso-margin-top-alt:auto; 192 margin-right:0cm; 193 mso-margin-bottom-alt:auto; 194 margin-left:0cm; 195 line-height:0%; 196 mso-pagination:widow-orphan; 197 font-size:7.5pt; 198 font-family:"Times New Roman"; 199 mso-fareast-font-family:"Times New Roman";} 200p.smalldark, li.smalldark, div.smalldark 201 {mso-style-name:smalldark; 202 mso-margin-top-alt:auto; 203 margin-right:0cm; 204 mso-margin-bottom-alt:auto; 205 margin-left:0cm; 206 line-height:7.5pt; 207 mso-pagination:widow-orphan; 208 font-size:7.5pt; 209 font-family:"Times New Roman"; 210 mso-fareast-font-family:"Times New Roman";} 211p.sectionentry1, li.sectionentry1, div.sectionentry1 212 {mso-style-name:sectionentry1; 213 mso-margin-top-alt:auto; 214 margin-right:0cm; 215 mso-margin-bottom-alt:auto; 216 margin-left:0cm; 217 mso-pagination:widow-orphan; 218 background:#EFEFEF; 219 font-size:7.5pt; 220 font-family:"Times New Roman"; 221 mso-fareast-font-family:"Times New Roman";} 222p.sectiontableentry2, li.sectiontableentry2, div.sectiontableentry2 223 {mso-style-name:sectiontableentry2; 224 mso-margin-top-alt:auto; 225 margin-right:0cm; 226 mso-margin-bottom-alt:auto; 227 margin-left:0cm; 228 mso-pagination:widow-orphan; 229 background:white; 230 font-size:7.5pt; 231 font-family:"Times New Roman"; 232 mso-fareast-font-family:"Times New Roman";} 233p.button, li.button, div.button 234 {mso-style-name:button; 235 margin:0cm; 236 margin-bottom:.0001pt; 237 line-height:7.5pt; 238 mso-pagination:widow-orphan; 239 border:none; 240 mso-padding-alt:0cm 0cm 0cm 0cm; 241 font-size:7.5pt; 242 font-family:"Times New Roman"; 243 mso-fareast-font-family:"Times New Roman"; 244 color:#002E61;} 245p.inputbox, li.inputbox, div.inputbox 246 {mso-style-name:inputbox; 247 margin:0cm; 248 margin-bottom:.0001pt; 249 line-height:10.5pt; 250 mso-pagination:widow-orphan; 251 border:none; 252 mso-padding-alt:0cm 0cm 0cm 0cm; 253 font-size:7.5pt; 254 font-family:"Times New Roman"; 255 mso-fareast-font-family:"Times New Roman"; 256 color:#002E61;} 257p.createdate, li.createdate, div.createdate 258 {mso-style-name:createdate; 259 mso-margin-top-alt:auto; 260 margin-right:0cm; 261 mso-margin-bottom-alt:auto; 262 margin-left:0cm; 263 line-height:0%; 264 mso-pagination:widow-orphan; 265 font-size:7.5pt; 266 font-family:"Times New Roman"; 267 mso-fareast-font-family:"Times New Roman";} 268p.modifydate, li.modifydate, div.modifydate 269 {mso-style-name:modifydate; 270 mso-margin-top-alt:auto; 271 margin-right:0cm; 272 margin-bottom:3.75pt; 273 margin-left:0cm; 274 line-height:15.0pt; 275 mso-pagination:widow-orphan; 276 font-size:7.5pt; 277 font-family:"Times New Roman"; 278 mso-fareast-font-family:"Times New Roman";} 279p.blogmore, li.blogmore, div.blogmore 280 {mso-style-name:blog_more; 281 mso-margin-top-alt:auto; 282 margin-right:0cm; 283 mso-margin-bottom-alt:auto; 284 margin-left:0cm; 285 mso-pagination:widow-orphan; 286 font-size:7.5pt; 287 font-family:"Times New Roman"; 288 mso-fareast-font-family:"Times New Roman";} 289p.blog, li.blog, div.blog 290 {mso-style-name:blog; 291 mso-margin-top-alt:auto; 292 margin-right:0cm; 293 mso-margin-bottom-alt:auto; 294 margin-left:0cm; 295 mso-pagination:widow-orphan; 296 font-size:12.0pt; 297 font-family:"Times New Roman"; 298 mso-fareast-font-family:"Times New Roman";} 299p.contentheading, li.contentheading, div.contentheading 300 {mso-style-name:contentheading; 301 mso-margin-top-alt:auto; 302 margin-right:0cm; 303 mso-margin-bottom-alt:auto; 304 margin-left:0cm; 305 line-height:15.0pt; 306 mso-pagination:widow-orphan; 307 border:none; 308 mso-border-bottom-alt:solid #002E61 .75pt; 309 padding:0cm; 310 mso-padding-alt:0cm 0cm 0cm 0cm; 311 font-size:12.0pt; 312 mso-fareast-font-family:"Times New Roman"; 313 mso-bidi-font-family:"Times New Roman"; 314 font-weight:bold;} 315p.contentpaneopen, li.contentpaneopen, div.contentpaneopen 316 {mso-style-name:contentpaneopen; 317 mso-margin-top-alt:auto; 318 margin-right:0cm; 319 mso-margin-bottom-alt:auto; 320 margin-left:0cm; 321 mso-pagination:widow-orphan; 322 font-size:7.5pt; 323 font-family:"Times New Roman"; 324 mso-fareast-font-family:"Times New Roman";} 325p.contentdescription, li.contentdescription, div.contentdescription 326 {mso-style-name:contentdescription; 327 mso-margin-top-alt:auto; 328 margin-right:0cm; 329 mso-margin-bottom-alt:auto; 330 margin-left:0cm; 331 mso-pagination:widow-orphan; 332 font-size:7.5pt; 333 font-family:"Times New Roman"; 334 mso-fareast-font-family:"Times New Roman";} 335p.sectiontableheader, li.sectiontableheader, div.sectiontableheader 336 {mso-style-name:sectiontableheader; 337 mso-margin-top-alt:auto; 338 margin-right:0cm; 339 mso-margin-bottom-alt:auto; 340 margin-left:0cm; 341 line-height:18.75pt; 342 mso-pagination:widow-orphan; 343 font-size:7.5pt; 344 font-family:"Times New Roman"; 345 mso-fareast-font-family:"Times New Roman"; 346 font-weight:bold;} 347p.categorytitle, li.categorytitle, div.categorytitle 348 {mso-style-name:categorytitle; 349 mso-margin-top-alt:auto; 350 margin-right:0cm; 351 mso-margin-bottom-alt:auto; 352 margin-left:0cm; 353 line-height:18.75pt; 354 mso-pagination:widow-orphan; 355 font-size:12.0pt; 356 mso-fareast-font-family:"Times New Roman"; 357 mso-bidi-font-family:"Times New Roman"; 358 font-weight:bold;} 359p.componentheading, li.componentheading, div.componentheading 360 {mso-style-name:componentheading; 361 mso-margin-top-alt:auto; 362 margin-right:0cm; 363 margin-bottom:3.75pt; 364 margin-left:0cm; 365 line-height:15.0pt; 366 mso-pagination:widow-orphan; 367 border:none; 368 mso-border-bottom-alt:solid #002E61 .75pt; 369 padding:0cm; 370 mso-padding-alt:0cm 0cm 0cm 0cm; 371 font-size:12.0pt; 372 mso-fareast-font-family:"Times New Roman"; 373 mso-bidi-font-family:"Times New Roman"; 374 font-weight:bold;} 375p.poll, li.poll, div.poll 376 {mso-style-name:poll; 377 mso-margin-top-alt:auto; 378 margin-right:0cm; 379 mso-margin-bottom-alt:auto; 380 margin-left:0cm; 381 text-align:center; 382 mso-pagination:widow-orphan; 383 font-size:7.5pt; 384 font-family:"Times New Roman"; 385 mso-fareast-font-family:"Times New Roman";} 386p.blogsection, li.blogsection, div.blogsection 387 {mso-style-name:blogsection; 388 mso-margin-top-alt:auto; 389 margin-right:0cm; 390 mso-margin-bottom-alt:auto; 391 margin-left:0cm; 392 mso-pagination:widow-orphan; 393 font-size:7.5pt; 394 font-family:"Times New Roman"; 395 mso-fareast-font-family:"Times New Roman";} 396p.mosimage, li.mosimage, div.mosimage 397 {mso-style-name:mosimage; 398 margin:3.75pt; 399 mso-pagination:widow-orphan; 400 border:none; 401 mso-border-alt:solid #CCCCCC .75pt; 402 padding:0cm; 403 mso-padding-alt:0cm 0cm 0cm 0cm; 404 font-size:12.0pt; 405 font-family:"Times New Roman"; 406 mso-fareast-font-family:"Times New Roman";} 407p.mosimagecaption, li.mosimagecaption, div.mosimagecaption
408 {mso-style-name:mosimage_caption; 409 margin-top:1.5pt; 410 margin-right:0cm; 411 mso-margin-bottom-alt:auto; 412 margin-left:0cm; 413 mso-pagination:widow-orphan; 414 background:#EFEFEF; 415 border:none; 416 mso-border-top-alt:solid #CCCCCC .75pt; 417 padding:0cm; 418 mso-padding-alt:1.0pt 0cm 0cm 0cm; 419 font-size:7.5pt; 420 font-family:"Times New Roman"; 421 mso-fareast-font-family:"Times New Roman"; 422 color:#666666;} 423p.inputbox1, li.inputbox1, div.inputbox1 424 {mso-style-name:inputbox1; 425 margin:0cm; 426 margin-bottom:.0001pt; 427 line-height:10.5pt; 428 mso-pagination:widow-orphan; 429 font-size:7.5pt; 430 font-family:"Times New Roman"; 431 mso-fareast-font-family:"Times New Roman"; 432 color:#002E61;} 433p.button1, li.button1, div.button1 434 {mso-style-name:button1; 435 margin:0cm; 436 margin-bottom:.0001pt; 437 line-height:7.5pt; 438 mso-pagination:widow-orphan; 439 font-size:7.5pt; 440 font-family:"Times New Roman"; 441 mso-fareast-font-family:"Times New Roman"; 442 color:#002E61;} 443span.pathway1 444 {mso-style-name:pathway1; 445 mso-ansi-font-size:7.5pt; 446 mso-bidi-font-size:7.5pt; 447 color:#BBBBBB; 448 mso-text-animation:none; 449 font-weight:normal; 450 text-decoration:none; 451 text-underline:none; 452 text-decoration:none; 453 text-line-through:none;} 454span.small1 455 {mso-style-name:small1; 456 mso-ansi-font-size:7.5pt; 457 mso-bidi-font-size:7.5pt; 458 color:#ABABAB;} 459span.SpellE 460 {mso-style-name:""; 461 mso-spl-e:yes;} 462span.GramE 463 {mso-style-name:""; 464 mso-gram-e:yes;} 465@page Section1 466 {size:595.3pt 841.9pt; 467 margin:72.0pt 90.0pt 72.0pt 90.0pt; 468 mso-header-margin:35.4pt; 469 mso-footer-margin:35.4pt; 470 mso-paper-source:0;} 471div.Section1 472 {page:Section1;} 473 /* List Definitions */ 474 @list l0 475 {mso-list-id:1116293873; 476 mso-list-template-ids:-1433794616;} 477@list l0:level1 478 {mso-level-number-format:bullet; 479 mso-level-text:\F0B7; 480 mso-level-tab-stop:36.0pt; 481 mso-level-number-position:left; 482 text-indent:-18.0pt; 483 mso-ansi-font-size:10.0pt; 484 font-family:Symbol;} 485@list l0:level2 486 {mso-level-tab-stop:72.0pt; 487 mso-level-number-position:left; 488 text-indent:-18.0pt;} 489@list l0:level3 490 {mso-level-tab-stop:108.0pt; 491 mso-level-number-position:left; 492 text-indent:-18.0pt;} 493@list l0:level4 494 {mso-level-tab-stop:144.0pt; 495 mso-level-number-position:left; 496 text-indent:-18.0pt;} 497@list l0:level5 498 {mso-level-tab-stop:180.0pt; 499 mso-level-number-position:left; 500 text-indent:-18.0pt;} 501@list l0:level6 502 {mso-level-tab-stop:216.0pt; 503 mso-level-number-position:left; 504 text-indent:-18.0pt;} 505@list l0:level7 506 {mso-level-tab-stop:252.0pt; 507 mso-level-number-position:left; 508 text-indent:-18.0pt;} 509@list l0:level8 510 {mso-level-tab-stop:288.0pt; 511 mso-level-number-position:left; 512 text-indent:-18.0pt;} 513@list l0:level9 514 {mso-level-tab-stop:324.0pt; 515 mso-level-number-position:left; 516 text-indent:-18.0pt;} 517@list l1 518 {mso-list-id:1847674910; 519 mso-list-template-ids:-1088285798;} 520@list l1:level1 521 {mso-level-number-format:bullet; 522 mso-level-text:\F0A7; 523 mso-level-tab-stop:36.0pt; 524 mso-level-number-position:left; 525 text-indent:-18.0pt; 526 mso-ansi-font-size:10.0pt; 527 font-family:Wingdings;} 528@list l1:level2 529 {mso-level-tab-stop:72.0pt; 530 mso-level-number-position:left; 531 text-indent:-18.0pt;} 532@list l1:level3 533 {mso-level-tab-stop:108.0pt; 534 mso-level-number-position:left; 535 text-indent:-18.0pt;} 536@list l1:level4 537 {mso-level-tab-stop:144.0pt; 538 mso-level-number-position:left; 539 text-indent:-18.0pt;} 540@list l1:level5 541 {mso-level-tab-stop:180.0pt; 542 mso-level-number-position:left; 543 text-indent:-18.0pt;} 544@list l1:level6 545 {mso-level-tab-stop:216.0pt; 546 mso-level-number-position:left; 547 text-indent:-18.0pt;} 548@list l1:level7 549 {mso-level-tab-stop:252.0pt; 550 mso-level-number-position:left; 551 text-indent:-18.0pt;} 552@list l1:level8 553 {mso-level-tab-stop:288.0pt; 554 mso-level-number-position:left; 555 text-indent:-18.0pt;} 556@list l1:level9 557 {mso-level-tab-stop:324.0pt; 558 mso-level-number-position:left; 559 text-indent:-18.0pt;} 560ol 561 {margin-bottom:0cm;} 562ul 563 {margin-bottom:0cm;} 564--> 565</style> 566<!--[if gte mso 10]> 567<style> 568 /* Style Definitions */ 569 table.MsoNormalTable 570 {mso-style-name:"Table Normal"; 571 mso-tstyle-rowband-size:0; 572 mso-tstyle-colband-size:0; 573 mso-style-noshow:yes; 574 mso-style-parent:""; 575 mso-padding-alt:0cm 5.4pt 0cm 5.4pt; 576 mso-para-margin:0cm; 577 mso-para-margin-bottom:.0001pt; 578 mso-pagination:widow-orphan; 579 font-size:10.0pt; 580 font-family:"Times New Roman"; 581 mso-ansi-language:#0400; 582 mso-fareast-language:#0400; 583 mso-bidi-language:#0400;} 584</style> 585<![endif]--> 586<meta name=title 587content="Nanorobot pioneer reveals status of simulator, stem cell work"> 588<meta name=author content="Adriano Cavalcanti"> 589<meta name=description 590content="NanoDelta international network of communities re nanotechnology. An independant platform with news and views for all stakeholders."> 591<meta name=keywords 592content="Nanotechnology, nanotechnology, Nanotechnologie, nanotechnologie, Nano, nano"> 593<meta name=robots content="index, follow"> 594<link rel="shortcut icon" href="http://www.merlinq.nl/images/favicon.ico"> 595<!--[if gte mso 9]><xml> 596 <o:shapedefaults v:ext="edit" spidmax="1026"/> 597</xml><![endif]--><!--[if gte mso 9]><xml> 598 <o:shapelayout v:ext="edit"> 599 <o:idmap v:ext="edit" data="1"/> 600 </o:shapelayout></xml><![endif]--> 601</head> 602 603<body bgcolor=white background="images_blue/back_verlauf.jpg" lang=EN-AU 604link="#002E61" vlink="#002E61" style='tab-interval:36.0pt'> 605 606<div class=Section1> 607 608<div id=accessibility> 609 610<p class=MsoNormal><span style='font-family:Verdana;display:none;mso-hide:all'><a 611href="http://www.merlinq.nl/index.php#menu"><b>Menu</b></a> <a 612href="http://www.merlinq.nl/index.php#content"><b>Content/<span class=SpellE>Inhalt</span></b></a> 613<o:p></o:p></span></p> 614 615</div> 616 617<form> 618 619<div> 620 621<p class=MsoNormal style='vertical-align:top'><span style='font-family:Verdana'><INPUT TYPE="text" MAXLENGTH="20" SIZE="20" NAME="searchword" VALUE="search..." 622id="mod_search_searchword" alt=search 623onblur="if(this.value=='') this.value='search...';" 624onfocus="if(this.value=='search...') this.value='';"><o:p></o:p></span></p> 625 626</div> 627 628<p class=MsoNormal style='vertical-align:top'><span style='font-family:Verdana; 629display:none;mso-hide:all'><INPUT TYPE="hidden" NAME="option" VALUE="com_search"><INPUT TYPE="hidden" NAME="Itemid" VALUE="5"></span><span 630style='font-family:Verdana'><!-- <div id="pagewidth-1024" > --><o:p></o:p></span></p> 631 632</form> 633 634<!-- end of 'div search --> 635 636<div id=topmenu> 637 638<p class=MsoNormal style='margin-top:0cm;margin-right:.75pt;margin-bottom:0cm; 639margin-left:0cm;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:15.0pt; 640mso-list:l0 level1 lfo2;tab-stops:list 36.0pt'><![if !supportLists]><span 641style='font-size:10.0pt;mso-bidi-font-size:7.5pt;font-family:Symbol;mso-fareast-font-family: 642Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span 643style='font:7.0pt "Times New Roman"'> 644</span></span></span><![endif]><span style='font-family:Verdana;display:none; 645mso-hide:all'>
645<script type="text/javascript"> 646 <!--//--><![CDATA[//><!-- 647 sfHover = function() { 648 var sfEls = document.getElementById("topmenu").getElementsByTagName("li"); 649 for (var i=0; i<sfEls.length; i++) { 650 sfEls[i].onmouseover=function() { 651 this.className+="sfhover"; 652 } 653 sfEls[i].onmouseout=function() { 654 this.className=this.className.replace(new RegExp("sfhover\\b"), ""); 655 } 656 } 657 } 658 if (window.attachEvent) window.attachEvent("onload", sfHover); 659 660 //--><!]]> 661</script>
661</span><span style='font-size:7.5pt;font-family:Verdana'><a 662href="http://www.merlinq.nl/index.php?option=com_content&task=view&id=169&Itemid=76"><span 663style='color:#CCCCCC;mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'>ABOUT<span 664class=GramE>..</span></span></a><o:p></o:p></span></p> 665 666<p class=MsoNormal style='margin-top:0cm;margin-right:.75pt;margin-bottom:0cm; 667margin-left:0cm;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:15.0pt; 668mso-list:l0 level1 lfo2;tab-stops:list 36.0pt'><![if !supportLists]><span 669style='font-size:10.0pt;mso-bidi-font-size:7.5pt;font-family:Symbol;mso-fareast-font-family: 670Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span 671style='font:7.0pt "Times New Roman"'> 672</span></span></span><![endif]><span style='font-size:7.5pt;font-family:Verdana'><a 673href="http://www.merlinq.nl/index.php?option=com_joomlaboard&Itemid=134"><span 674style='color:#CCCCCC;mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'>FORUM</span></a><o:p></o:p></span></p> 675 676<p class=MsoNormal style='margin-top:0cm;margin-right:.75pt;margin-bottom:0cm; 677margin-left:0cm;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:15.0pt; 678mso-list:l0 level1 lfo2;tab-stops:list 36.0pt'><![if !supportLists]><span 679style='font-size:10.0pt;mso-bidi-font-size:7.5pt;font-family:Symbol;mso-fareast-font-family: 680Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span 681style='font:7.0pt "Times New Roman"'> 682</span></span></span><![endif]><span style='font-size:7.5pt;font-family:Verdana'><a 683href="http://www.merlinq.nl/index.php?option=com_comprofiler&task=usersList&Itemid=125"><span 684style='color:#CCCCCC;mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'>WHO</span></a><o:p></o:p></span></p> 685 686<p class=MsoNormal style='margin-top:0cm;margin-right:.75pt;margin-bottom:0cm; 687margin-left:0cm;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:15.0pt; 688mso-list:l0 level1 lfo2;tab-stops:list 36.0pt'><![if !supportLists]><span 689style='font-size:10.0pt;mso-bidi-font-size:7.5pt;font-family:Symbol;mso-fareast-font-family: 690Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span 691style='font:7.0pt "Times New Roman"'> 692</span></span></span><![endif]><span style='font-size:7.5pt;font-family:Verdana'><a 693href="http://www.merlinq.nl/index.php"><span style='color:#CCCCCC;mso-ansi-font-weight: 694normal;mso-bidi-font-weight:normal'>HOME</span></a><o:p></o:p></span></p> 695 696</div> 697 698<!-- end of div 'topmenu' --><!-- end of 'top-top' --> 699 700<div id=top-bottom> 701 702<p class=MsoNormal><span style='font-family:Verdana'><a 703href="http://www.merlinq.nl/index.php"><b><img border=0 width=400 height=70 704id="_x0000_i1029" src="index_files/logo.gif"></b></a><o:p></o:p></span></p> 705 706</div> 707 708<p class=MsoNormal align=center style='text-align:center;background:white'><span 709style='font-family:Verdana'><a 710href="http://www.merlinq.nl/index.php?option=com_banners&task=click&bid=17" 711target="_blank"><b><!-- end of div 'top-bottom' --><img border=0 width=208 712height=68 id="_x0000_i1030" src="index_files/10_NT_banner.jpg" 713alt=Advertisement></b></a><o:p></o:p></span></p> 714 715<!-- end of div 'header' --> 716 717<div id=outer-1024> 718 719<div id=pathway> 720 721<p class=MsoNormal><span class=pathway1><span style='font-size:7.5pt; 722font-family:Verdana'>HOME </span></span><span style='font-family:Verdana'><o:p></o:p></span></p> 723 724</div> 725 726<!-- KPTABLE: invoegen van 3-column layout-table ter voorkoming van opschuiven Right --><!-- KPTABLE: start DIV --><!-- KPTABLE: linker kolom --> 727 728<div id=KPTABLE> 729 730<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" 731 style='width:100.0%;mso-cellspacing:0cm;mso-padding-alt:0cm 0cm 0cm 0cm'> 732 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'> 733 <td valign=top style='padding:0cm 0cm 0cm 0cm'> 734 <div style='margin-right:3.75pt' id=leftcol> 735 <div style='margin-bottom:7.5pt'> 736 <div> 737 <div> 738 <div> 739 <table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" 740 style='width:100.0%;mso-cellspacing:0cm;mso-padding-alt:0cm 0cm 0cm 0cm'> 741 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'> 742 <td style='padding:0cm 0cm 0cm 0cm'> 743 <p class=MsoNormal><a name=menu></a><span style='font-family:Verdana'><a 744 href="http://www.merlinq.nl/index.php?option=com_content&task=blogsection&id=0&Itemid=73"><span 745 style='font-size:7.5pt;mso-ansi-font-weight:normal;mso-bidi-font-weight: 746 normal'>
746INTERNATIONAL NEWS</span></a><o:p></o:p></span></p> 747 </td> 748 </tr> 749 <tr style='mso-yfti-irow:1'> 750 <td style='padding:0cm 0cm 0cm 0cm'> 751 <p class=MsoNormal><span style='font-family:Verdana'><a 752 href="http://www.merlinq.nl/index.php?option=com_content&task=section&id=8&Itemid=74"><span 753 style='font-size:7.5pt;mso-ansi-font-weight:normal;mso-bidi-font-weight: 754 normal'>CATEGORIES</span></a><o:p></o:p></span></p> 755 </td> 756 </tr> 757 <tr style='mso-yfti-irow:2'> 758 <td style='padding:0cm 0cm 0cm 0cm'> 759 <p class=MsoNormal><span style='font-family:Verdana'><a 760 href="http://www.merlinq.nl/index.php?option=com_search&Itemid=5"><span 761 style='font-size:7.5pt;mso-ansi-font-weight:normal;mso-bidi-font-weight: 762 normal'>SEARCH</span></a><o:p></o:p></span></p> 763 </td> 764 </tr> 765 <tr style='mso-yfti-irow:3'> 766 <td style='padding:0cm 0cm 0cm 0cm'> 767 <p class=MsoNormal><span style='font-family:Verdana'><a 768 href="http://www.merlinq.nl/index.php?option=com_comprofiler&task=usersList&listid=5&Itemid=130"><span 769 style='font-size:7.5pt;mso-ansi-font-weight:normal;mso-bidi-font-weight: 770 normal'>WRITERS</span></a><o:p></o:p></span></p> 771 </td> 772 </tr> 773 <tr style='mso-yfti-irow:4'> 774 <td style='padding:0cm 0cm 0cm 0cm'> 775 <p class=MsoNormal><span style='font-family:Verdana'><a 776 href="http://www.merlinq.nl/index.php?option=com_extcalendar&Itemid=137"><span 777 style='font-size:7.5pt;mso-ansi-font-weight:normal;mso-bidi-font-weight: 778 normal'>EVENTS</span></a><o:p></o:p></span></p> 779 </td> 780 </tr> 781 <tr style='mso-yfti-irow:5;mso-yfti-lastrow:yes'> 782 <td style='padding:0cm 0cm 0cm 0cm'> 783 <p class=MsoNormal><span style='font-family:Verdana'><a 784 href="http://www.merlinq.nl/index.php?option=com_newsfeeds&Itemid=93"><span 785 style='font-size:7.5pt;mso-ansi-font-weight:normal;mso-bidi-font-weight: 786 normal'>FEEDS</span></a><o:p></o:p></span></p> 787 </td> 788 </tr> 789 </table> 790 </div> 791 </div> 792 </div> 793 </div> 794 <table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" 795 style='width:100.0%;mso-cellspacing:0cm;mso-padding-alt:0cm 0cm 0cm 0cm'> 796 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'> 797 <td style='padding:0cm 0cm 0cm 0cm'> 798 <p class=MsoNormal><span style='font-family:Verdana'><a 799 href="http://www.merlinq.nl/index.php?option=com_content&task=view&id=170&Itemid=81"><span 800 style='font-size:7.5pt;mso-ansi-font-weight:normal;mso-bidi-font-weight: 801 normal'>REGIONAL NEWS</span></a><o:p></o:p></span></p> 802 </td> 803 </tr> 804 <tr style='mso-yfti-irow:1;mso-yfti-lastrow:yes'> 805 <td style='padding:0cm 0cm 0cm 0cm'> 806 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 807 width=30 height=20 id="_x0000_i1250" 808 src="index_files/FL_nl-flag_netherlands_xxs.jpg" alt="NL - Nederland"><a 809 href="http://www.merlinq.nl/index.php?option=com_content&task=blogsection&id=6&Itemid=79"><span 810 style='font-size:7.5pt;mso-ansi-font-weight:normal;mso-bidi-font-weight: 811 normal'>NL - Nederland</span></a><o:p></o:p></span></p> 812 </td> 813 </tr> 814 </table> 815 <div style='margin-bottom:7.5pt'> 816 <div> 817 <div> 818 <div> 819 <p class=MsoNormal><span style='font-size:7.5pt;font-family:Verdana; 820 display:none;mso-hide:all'><o:p> </o:p></span></p> 821 <table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" 822 style='width:100.0%;mso-cellspacing:0cm;mso-padding-alt:0cm 0cm 0cm 0cm'> 823 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'> 824 <td style='padding:0cm 0cm 0cm 0cm'> 825 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 826 width=75 height=56 id="_x0000_i1251" src="index_files/nd_guestwriters_s.jpg" 827 alt=GuestWriters><a 828 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=158&Itemid=132"><span 829 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 830 mso-bidi-font-weight:normal'>GuestWriters</span></span></a><o:p></o:p></span></p> 831 </td> 832 </tr> 833 <tr style='mso-yfti-irow:1'> 834 <td style='padding:0cm 0cm 0cm 0cm'> 835 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 836 width=75 height=56 id="_x0000_i1252" src="index_files/ND_FutureTech_s.jpg" 837 alt="Future Technology"><a 838 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=132&Itemid=68"><span 839 style='font-size:7.5pt;mso-ansi-font-weight:normal;mso-bidi-font-weight: 840 normal'>Future Technology</span></a><o:p></o:p></span></p> 841 </td> 842 </tr> 843 <tr style='mso-yfti-irow:2'> 844 <td style='padding:0cm 0cm 0cm 0cm'> 845 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 846 width=75 height=56 id="_x0000_i1253" src="index_files/ND_Battery_s.jpg" 847 alt="Nano Batteries"><a 848 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=131&Itemid=69"><span 849 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 850 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 851 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Batteries</span></a><o:p></o:p></span></p> 852 </td> 853 </tr> 854 <tr style='mso-yfti-irow:3'> 855 <td style='padding:0cm 0cm 0cm 0cm'> 856 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 857 width=75 height=56 id="_x0000_i1254" src="index_files/ND_NanoBooks_s.jpg" 858 alt="Nano Books"><a 859 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=148&Itemid=95"><span 860 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 861 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 862 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Books</span></a><o:p></o:p></span></p> 863 </td> 864 </tr> 865 <tr style='mso-yfti-irow:4'> 866 <td style='padding:0cm 0cm 0cm 0cm'> 867 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 868 width=75 height=56 id="_x0000_i1255" src="index_files/ND_NanoBiz_s.jpg" 869 alt="Nano Biz"><a 870 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=135&Itemid=72"><span 871 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 872 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 873 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Biz</span></a><o:p></o:p></span></p> 874 </td> 875 </tr> 876 <tr style='mso-yfti-irow:5'> 877 <td style='padding:0cm 0cm 0cm 0cm'> 878 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 879 width=75 height=56 id="_x0000_i1256" src="index_files/ND_Coatings_s.jpg" 880 alt="Nano Coatings"><a 881 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=133&Itemid=70"><span 882 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 883 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 884 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Coatings</span></a><o:p></o:p></span></p> 885 </td> 886 </tr> 887 <tr style='mso-yfti-irow:6'> 888 <td style='padding:0cm 0cm 0cm 0cm'> 889 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 890 width=75 height=56 id="_x0000_i1257" src="index_files/ND_NanoDebate_s.jpg" 891 alt="Nano Debate"><a 892 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=134&Itemid=71"><span 893 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 894 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 895 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Debate</span></a><o:p></o:p></span></p> 896 </td> 897 </tr> 898 <tr style='mso-yfti-irow:7'> 899 <td style='padding:0cm 0cm 0cm 0cm'> 900 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 901 width=75 height=56 id="_x0000_i1258" src="index_files/ND_Defence_s.jpg" 902 alt="Nano Defense"><a 903 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=137&Itemid=96"><span 904 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 905 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 906 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> <span 907 class=SpellE>Defense</span></span></a><o:p></o:p></span></p> 908 </td> 909 </tr> 910 <tr style='mso-yfti-irow:8'> 911 <td style='padding:0cm 0cm 0cm 0cm'> 912 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 913 width=75 height=56 id="_x0000_i1259" src="index_files/ND_Electronics_s.jpg" 914 alt="Nano Electronics"><a 915 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=138&Itemid=97"><span 916 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 917 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 918 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Electronics</span></a><o:p></o:p></span></p> 919 </td> 920 </tr> 921 <tr style='mso-yfti-irow:9'> 922 <td style='padding:0cm 0cm 0cm 0cm'> 923 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 924 width=75 height=56 id="_x0000_i1260" src="index_files/ND_Energy_s.jpg" 925 alt="Nano Energy"><a 926 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=139&Itemid=98"><span 927 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 928 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 929 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Energy</span></a><o:p></o:p></span></p> 930 </td> 931 </tr> 932 <tr style='mso-yfti-irow:10'> 933 <td style='padding:0cm 0cm 0cm 0cm'> 934 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 935 width=75 height=56 id="_x0000_i1261" src="index_files/ND_Event_s.jpg" 936 alt="Nano Events"><a 937 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=159&Itemid=99"><span 938 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 939 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 940 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Events</span></a><o:p></o:p></span></p> 941 </td> 942 </tr> 943 <tr style='mso-yfti-irow:11'> 944 <td style='padding:0cm 0cm 0cm 0cm'> 945 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 946 width=75 height=56 id="_x0000_i1262" src="index_files/ND_Environment_s.jpg" 947 alt=Environment><a 948 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=140&Itemid=100"><span 949 style='font-size:7.5pt;mso-ansi-font-weight:normal;mso-bidi-font-weight: 950 normal'>Environment</span></a><o:p></o:p></span></p> 951 </td> 952 </tr> 953 <tr style='mso-yfti-irow:12'> 954 <td style='padding:0cm 0cm 0cm 0cm'> 955 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 956 width=75 height=56 id="_x0000_i1263" src="index_files/ND_Food_s.jpg" 957 alt="Nano Food"><a 958 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=141&Itemid=101"><span 959 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 960 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 961 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Food</span></a><o:p></o:p></span></p> 962 </td> 963 </tr> 964 <tr style='mso-yfti-irow:13'> 965 <td style='padding:0cm 0cm 0cm 0cm'> 966 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 967 width=75 height=56 id="_x0000_i1264" src="index_files/ND_Imprint_s.jpg" 968 alt="Nano Imprint"><a 969 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=142&Itemid=102"><span 970 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 971 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 972 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Imprint</span></a><o:p></o:p></span></p> 973 </td> 974 </tr> 975 <tr style='mso-yfti-irow:14'> 976 <td style='padding:0cm 0cm 0cm 0cm'> 977 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 978 width=75 height=52 id="_x0000_i1265" src="index_files/ND_Investments_s.jpg" 979 alt="Nano Investment"><a 980 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=143&Itemid=103"><span 981 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 982 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 983 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Investment</span></a><o:p></o:p></span></p> 984 </td> 985 </tr> 986 <tr style='mso-yfti-irow:15'> 987 <td style='padding:0cm 0cm 0cm 0cm'> 988 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 989 width=75 height=56 id="_x0000_i1266" src="index_files/ND_Medicine_s.jpg" 990 alt="Nano Medicine"><a 991 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=144&Itemid=104"><span 992 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 993 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 994 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Medicine</span></a><o:p></o:p></span></p> 995 </td> 996 </tr> 997 <tr style='mso-yfti-irow:16'> 998 <td style='padding:0cm 0cm 0cm 0cm'> 999 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 1000 width=75 height=56 id="_x0000_i1267" src="index_files/ND_Meet_s.jpg" 1001 alt="Nano Meet"><a 1002 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=145&Itemid=105"><span 1003 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 1004 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 1005 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Meet</span></a><o:p></o:p></span></p> 1006 </td> 1007 </tr> 1008 <tr style='mso-yfti-irow:17'> 1009 <td style='padding:0cm 0cm 0cm 0cm'> 1010 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 1011 width=75 height=75 id="_x0000_i1268" src="index_files/ND_Mems_s.jpg" 1012 alt=MEMS><a 1013 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=146&Itemid=106"><span 1014 style='font-size:7.5pt;mso-ansi-font-weight:normal;mso-bidi-font-weight: 1015 normal'>MEMS</span></a><o:p></o:p></span></p> 1016 </td> 1017 </tr> 1018 <tr style='mso-yfti-irow:18'> 1019 <td style='padding:0cm 0cm 0cm 0cm'> 1020 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 1021 width=75 height=56 id="_x0000_i1269" src="index_files/ND_Products_s.jpg" 1022 alt="Nano Products"><a 1023 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=150&Itemid=107"><span 1024 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 1025 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 1026 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Products</span></a><o:p></o:p></span></p> 1027 </td> 1028 </tr> 1029 <tr style='mso-yfti-irow:19'> 1030 <td style='padding:0cm 0cm 0cm 0cm'> 1031 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 1032 width=75 height=55 id="_x0000_i1270" src="index_files/ND_Reports_s.jpg" 1033 alt="Nano Reports"><a 1034 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=153&Itemid=108"><span 1035 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 1036 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 1037 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Reports</span></a><o:p></o:p></span></p> 1038 </td> 1039 </tr> 1040 <tr style='mso-yfti-irow:20'> 1041 <td style='padding:0cm 0cm 0cm 0cm'> 1042 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 1043 width=75 height=56 id="_x0000_i1271" src="index_files/ND_Research_s.jpg" 1044 alt="Nano Research"><a 1045 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=136&Itemid=109"><span 1046 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 1047 mso-bidi-font-weight:normal'>Nano</span></span><span s
1047tyle='font-size:7.5pt; 1048 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Research</span></a><o:p></o:p></span></p> 1049 </td> 1050 </tr> 1051 <tr style='mso-yfti-irow:21'> 1052 <td style='padding:0cm 0cm 0cm 0cm'> 1053 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 1054 width=75 height=56 id="_x0000_i1272" src="index_files/ND_Storage_s.jpg" 1055 alt="Nano Storage"><a 1056 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=155&Itemid=110"><span 1057 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 1058 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 1059 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Storage</span></a><o:p></o:p></span></p> 1060 </td> 1061 </tr> 1062 <tr style='mso-yfti-irow:22'> 1063 <td style='padding:0cm 0cm 0cm 0cm'> 1064 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 1065 width=75 height=52 id="_x0000_i1273" src="index_files/ND_Textiles_s.jpg" 1066 alt="Nano Textiles"><a 1067 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=156&Itemid=111"><span 1068 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 1069 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 1070 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Textiles</span></a><o:p></o:p></span></p> 1071 </td> 1072 </tr> 1073 <tr style='mso-yfti-irow:23'> 1074 <td style='padding:0cm 0cm 0cm 0cm'> 1075 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 1076 width=75 height=48 id="_x0000_i1274" src="index_files/ND_Tools_s.jpg" 1077 alt="Nano Tools"><a 1078 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=157&Itemid=112"><span 1079 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 1080 mso-bidi-font-weight:normal'>Nano</span></span><span style='font-size:7.5pt; 1081 mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'> Tools</span></a><o:p></o:p></span></p> 1082 </td> 1083 </tr> 1084 <tr style='mso-yfti-irow:24'> 1085 <td style='padding:0cm 0cm 0cm 0cm'> 1086 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 1087 width=75 height=56 id="_x0000_i1275" src="index_files/ND_Odd_s.jpg" 1088 alt="Odd News"><a 1089 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=149&Itemid=113"><span 1090 style='font-size:7.5pt;mso-ansi-font-weight:normal;mso-bidi-font-weight: 1091 normal'>Odd News</span></a><o:p></o:p></span></p> 1092 </td> 1093 </tr> 1094 <tr style='mso-yfti-irow:25'> 1095 <td style='padding:0cm 0cm 0cm 0cm'> 1096 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 1097 width=75 height=52 id="_x0000_i1276" src="index_files/ND_QuantumComp_s.jpg" 1098 alt="Quantum Computing"><a 1099 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=151&Itemid=114"><span 1100 style='font-size:7.5pt;mso-ansi-font-weight:normal;mso-bidi-font-weight: 1101 normal'>Quantum Computing</span></a><o:p></o:p></span></p> 1102 </td> 1103 </tr> 1104 <tr style='mso-yfti-irow:26'> 1105 <td style='padding:0cm 0cm 0cm 0cm'> 1106 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 1107 width=75 height=56 id="_x0000_i1277" src="index_files/ND_ReadingRoom_s.jpg" 1108 alt="Reading Room"><a 1109 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=152&Itemid=115"><span 1110 style='font-size:7.5pt;mso-ansi-font-weight:normal;mso-bidi-font-weight: 1111 normal'>Reading Room</span></a><o:p></o:p></span></p> 1112 </td> 1113 </tr> 1114 <tr style='mso-yfti-irow:27;mso-yfti-lastrow:yes'> 1115 <td style='padding:0cm 0cm 0cm 0cm'> 1116 <p class=MsoNormal><span style='font-family:Verdana'><img border=0 1117 width=75 height=56 id="_x0000_i1278" src="index_files/ND_Spintronics_s.jpg" 1118 alt=Spintronics><a 1119 href="http://www.merlinq.nl/index.php?option=com_content&task=blogcategory&id=154&Itemid=116"><span 1120 class=SpellE><span style='font-size:7.5pt;mso-ansi-font-weight:normal; 1121 mso-bidi-font-weight:normal'>Spintronics</span></span></a><o:p></o:p></span></p> 1122 </td> 1123 </tr> 1124 </table> 1125 </div> 1126 </div> 1127 </div> 1128 </div> 1129 </div> 1130<!-- end of div 'leftcol' --> 1131 <p class=MsoNormal><span style='font-size:7.5pt;font-family:Verdana'><o:p></o:p></span></p> 1132 </td> 1133<!-- KPTABLE: end of linker kolom --> 1134 <td valign=top style='padding:0cm 0cm 0cm 0cm'><!-- KPTABLE: midden kolom --> 1135 <div id=maincol-broad-1024> 1136 <div> 1137 <table class=MsoNormalTable border=0 cellpadding=0 width="98%" 1138 style='width:98.0%;mso-cellspacing:1.5pt;mso-padding-alt:0cm 5.4pt 0cm 5.4pt'> 1139 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes; 1140 height:17.25pt'> 1141 <td width="98%" style='width:98.0%;border:none;border-bottom:solid #002E61 1.0pt; 1142 mso-border-bottom-alt:solid #002E61 .75pt;padding:.75pt .75pt .75pt .75pt; 1143 height:17.25pt'> 1144 <p class=MsoNormal style='line-height:15.0pt'><a name=content></a><span 1145 class=SpellE><b><span style='font-family:"Trebuchet MS";color:#002E61'>Nanorobot</span></b></span><b><span 1146 style='font-family:"Trebuchet MS";color:#002E61'> pioneer reveals status of 1147 simulator, stem cell work <o:p></o:p></span></b></p> 1148 </td> 1149 <td width="100%" style='width:100.0%;padding:.75pt .75pt .75pt .75pt; 1150 height:17.25pt'> 1151 <p class=MsoNormal align=right style='text-align:right'><span 1152 style='font-size:7.5pt;font-family:Verdana'><a href="javascript:void(0)" 1153 title=PDF><b><img border=0 width=16 height=16 id="_x0000_i1279" 1154 src="index_files/pdf_button.png" alt=PDF name=PDF align=middle></b></a><o:p></o:p></span></p> 1155 </td> 1156 <td width="100%" style='width:100.0%;padding:.75pt .75pt .75pt .75pt; 1157 height:17.25pt'> 1158 <p class=MsoNormal align=right style='text-align:right'><span 1159 style='font-size:7.5pt;font-family:Verdana'><a href="javascript:void(0)" 1160 title=Print><b><img border=0 width=16 height=16 id="_x0000_i1280"
1161 src="index_files/printButton.png" alt=Print name=Print align=middle></b></a><o:p></o:p></span></p> 1162 </td> 1163 <td width="100%" style='width:100.0%;padding:.75pt .75pt .75pt .75pt; 1164 height:17.25pt'> 1165 <p class=MsoNormal align=right style='text-align:right'><span 1166 style='font-size:7.5pt;font-family:Verdana'><a href="javascript:void(0)" 1167 title=E-mail><b><img border=0 width=16 height=16 id="_x0000_i1281" 1168 src="index_files/emailButton.png" alt=E-mail name=E-mail align=middle></b></a><o:p></o:p></span></p> 1169 </td> 1170 </tr> 1171 </table> 1172 <p class=MsoNormal style='line-height:13.5pt'><span style='font-size:7.5pt; 1173 font-family:Verdana;display:none;mso-hide:all'><o:p> </o:p></span></p> 1174 <table class=MsoNormalTable border=0 cellpadding=0 width="98%" 1175 style='width:98.0%;mso-cellspacing:1.5pt;mso-padding-alt:0cm 5.4pt 0cm 5.4pt'> 1176 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'> 1177 <td width="70%" valign=top style='width:70.0%;padding:.75pt .75pt .75pt .75pt'> 1178 <p class=MsoNormal><span class=small1><span style='font-size:7.5pt; 1179 font-family:Verdana'>Written by <a 1180 href="http://www.merlinq.nl/index.php?option=com_comprofiler&task=userProfile&user=84"><b 1181 style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:Times; 1182 color:navy'>Jane <span class=SpellE>Salodof</span> <span class=SpellE>MacNeil</span></span></b><b> 1183 </b></a><span style='mso-spacerun:yes'> </span></span></span><span 1184 style='font-size:7.5pt;font-family:Verdana'> <o:p></o:p></span></p> 1185 </td> 1186 </tr> 1187 <tr style='mso-yfti-irow:1;height:7.5pt'> 1188 <td valign=top style='padding:.75pt .75pt .75pt .75pt;height:7.5pt'> 1189 <p class=MsoNormal style='line-height:0%'><span style='font-size:7.5pt; 1190 font-family:Verdana;color:#ABABAB'>Thursday, 24 February 2005 <o:p></o:p></span></p> 1191 </td> 1192 </tr> 1193 <tr style='mso-yfti-irow:2;mso-yfti-lastrow:yes'> 1194 <td valign=top style='padding:.75pt .75pt .75pt .75pt'> 1195 <div style='border:solid #CCCCCC 1.0pt;mso-border-alt:solid #CCCCCC .75pt; 1196 padding:0cm 0cm 0cm 0cm;margin-left:3.75pt;margin-top:3.75pt;margin-right: 1197 3.75pt;margin-bottom:3.75pt;float:right'> 1198 <p class=MsoNormal align=center style='text-align:center'><span 1199 style='font-size:7.5pt;font-family:Verdana'><img border=0 width=150 1200 height=143 id="_x0000_i1248" src="index_files/w00084_cavalcanti_adriano.jpg" 1201 hspace=6 alt="Adriano Cavalcanti" title="Adriano Cavalcanti"><o:p></o:p></span></p> 1202 <div style='border:none;border-top:solid #CCCCCC 1.0pt;mso-border-top-alt: 1203 solid #CCCCCC .75pt;padding:1.0pt 0cm 0cm 0cm;margin-top:1.5pt'> 1204 <p class=MsoNormal align=center style='text-align:center;background:#EFEFEF'><span 1205 style='font-size:7.5pt;font-family:Verdana;color:#666666'>Adriano <span 1206 class=SpellE>Cavalcanti</span><o:p></o:p></span></p> 1207 </div> 1208 </div> 1209 <p class=MsoNormal><span style='font-size:7.5pt;font-family:Verdana'>Adriano 1210 <span class=SpellE>Cavalcanti</span> is Chairman and CEO of <span 1211 class=SpellE>Center</span> for Automation in <span class=SpellE>Nanobiotech</span> 1212 (CAN) -- created in 2004 through the collaboration of private funds. CAN as 1213 a private company focuses on investigation of new paradigms for innovation 1214 in systems and automation design. CAN main thrust and aim is the 1215 development of commercial <span class=SpellE>nanobiotechnology</span> 1216 systems and devices that may benefit people around the globe with 1217 biomedical engineering advances.<o:p></o:p></span></p> 1218 <p><span style='font-size:7.5pt;font-family:Verdana'>Pedal back to 1966, 1219 and a miniaturized medical repair team caroming through the blood stream 1220 was the stuff of science fiction. Today the premise explored in the movie
1221 Fantastic Voyage is the stuff of nanotechnology, as scientists race to 1222 build <span class=SpellE>nanorobots</span> that can diagnose and heal the 1223 sick from within the human body. Human guinea pigs are a long way off, 1224 however.<o:p></o:p></span></p> 1225 <p><span style='font-size:7.5pt;font-family:Verdana'>Researchers need a way 1226 to design, test and refine <span class=SpellE>nanorobots</span> in 1227 real-life clinical conditions before they can hope to take <span 1228 class=SpellE>nanorobots</span> into the clinic.<o:p></o:p></span></p> 1229 <p><span style='font-size:7.5pt;font-family:Verdana'>Enter Adriano <span 1230 class=SpellE>Cavalcanti</span>, PhD, and his colleagues in the <st1:PlaceType 1231 w:st="on">School</st1:PlaceType> of <st1:PlaceName w:st="on">Electrical</st1:PlaceName> 1232 and Computer Engineering at the <st1:PlaceType w:st="on">University</st1:PlaceType> 1233 of <st1:PlaceName w:st="on">Campinas</st1:PlaceName> in <st1:country-region 1234 w:st="on"><st1:place w:st="on">Brazil</st1:place></st1:country-region>. 1235 They have designed a <span class=SpellE>Nanorobot</span> Control Design 1236 (NCD) simulator on which they are already exploring <span class=SpellE>aplications</span> 1237 in coronary disease and the use of stem cells to treat diabetes.<o:p></o:p></span></p> 1238 <p><span style='font-size:7.5pt;font-family:Verdana'>At the end of this 1239 month, <span class=SpellE>Cavalcanti</span> will describe this ongoing work 1240 toward making <span class=SpellE>nanorobots</span> viable in a tutorial at 1241 the American Society of Mechanical Engineers (ASME)’s Design 1242 Engineering Technical Conference in <st1:City w:st="on"><st1:place w:st="on">Salt 1243 Lake City</st1:place></st1:City>. In advance of that presentation, <span 1244 class=SpellE>NanoBiotech</span> News interviewed him about his own work and 1245 why he believes the field will produce the first working <span 1246 class=SpellE>nanorobots</span> within the next 10 years.<o:p></o:p></span></p> 1247 <p><span style='font-size:7.5pt;font-family:Verdana'>The Q&A follows:<o:p></o:p></span></p> 1248 <p><strong><span style='font-size:7.5pt;font-family:Verdana'>Q: What is the 1249 NCD simulator?</span></strong><span style='font-size:7.5pt;font-family: 1250 Verdana'><o:p></o:p></span></p> 1251 <p><span class=SpellE><span style='font-size:7.5pt;font-family:Verdana'>Cavalcanti</span></span><span 1252 style='font-size:7.5pt;font-family:Verdana'>: The NCD is software 1253 comprising several modules that simulate the physical conditions, run the <span 1254 class=SpellE>nanorobot</span> control programs determining their actions, 1255 provide a visual display of the environment in 3D, and record the history 1256 of <span class=SpellE>nanorobot</span> <span class=SpellE>behaviors</span> 1257 for later analysis. Our main thrust is toward implementing a practical, 1258 effective architecture and a scientifically valuable tool to enable 1259 investigation of <span class=SpellE>nanorobot</span> design, control, and 1260 automation. The range of applications envisioned is exciting, and a broad 1261 core of study cases is coming up. The possibility to customize code for new 1262 investigations is also a positive feature in the software. <o:p></o:p></span></p> 1263 <p><strong><span style='font-size:7.5pt;font-family:Verdana'>Q: What will 1264 be new in your presentation in <st1:City w:st="on"><st1:place w:st="on">Salt 1265 Lake City</st1:place></st1:City>?</span></strong><span style='font-size: 1266 7.5pt;font-family:Verdana'><o:p></o:p></span></p> 1267 <p><span class=SpellE><span style='font-size:7.5pt;font-family:Verdana'>Cavalcanti</span></span><span 1268 style='font-size:7.5pt;font-family:Verdana'>: The NCD has a modular 1269 architecture, and we are increasing gradually its complexity and the environment 1270 parameters -- as well as the different investigations in biomedical 1271 engineering applications. The work at the ASME conference will focus on the 1272 automation of <span class=SpellE>nanorobots</span> applied to controlling 1273 chemical concentrations for a 3D workspace monitored by <span class=SpellE>nanorobots</span>. 1274 <o:p></o:p></span></p> 1275 <p><span style='font-size:7.5pt;font-family:Verdana'>We are planning to 1276 include some new screen shots from the simulator. For example, in the 1277 coming months we will disclose the results from new work applying <span 1278 class=SpellE>nanorobots</span> to coronary problems, as well as a detailed 1279 investigation into <span class=SpellE>nanorobot</span> communication 1280 techniques. These new results will be fully available very soon with others 1281 we have previously published at <a 1282 href="http://www.nanorobotdesign.com/"><b>http://www.nanorobotdesign.com/</b></a>. 1283 <o:p></o:p></span></p> 1284 <p><strong><span style='font-size:7.5pt;font-family:Verdana'>Q: Why are 1285 computer-generated models necessary to the development of <span 1286 class=SpellE>nanorobots</span>?</span></strong><span style='font-size:7.5pt; 1287 font-family:Verdana'><o:p></o:p></span></p> 1288 <p><span class=SpellE><span style='font-size:7.5pt;font-family:Verdana'>Cavalcanti</span></span><span 1289 style='font-size:7.5pt;font-family:Verdana'>: The development of <span 1290 class=SpellE>nanorobots</span> is an emerging field with many open issues. 1291 Simulation is an essential tool for exploring alternatives in the 1292 organization, configuration, motion planning, and control of <span 1293 class=SpellE>nanodevices</span> exploring the human body. Simulation can 1294 include various levels of detail, giving a trade-off between physical 1295 accuracy and the ability to control large numbers of <span class=SpellE>nanorobots</span> 1296 over relevant time scales with reasonable computational effort.<o:p></o:p></span></p> 1297 <p><span style='font-size:7.5pt;font-family:Verdana'>Another advantage is 1298 that simulation can be done in advance of direct experimentation. 1299 Controlling large numbers of <span class=SpellE>nanorobots</span> is very 1300 challenging. It is most efficient to develop the control technology in 1301 tandem with the fabrication technologies, so that when we are able to build 1302 these devices, we will already have a good background in how to control 1303 them. <o:p></o:p></span></p> 1304 <p><span style='font-size:7.5pt;font-family:Verdana'>Hence, the design and 1305 the development of complex <span class=SpellE>nanosystems</span> with high 1306 performance can be well <span class=SpellE>analyzed</span> and addressed 1307 via simulation to help pave the way for future use of <span class=SpellE>nanorobots</span> 1308 in biomedical engineering problems. In vitro experimentation is at present 1309 possible only on the materials we expect to use in the fabrication of <sp
1309an 1310 class=SpellE>nanorobots</span> -- and not on entire <span class=SpellE>nanorobots</span>, 1311 which are still being developed. <o:p></o:p></span></p> 1312 <p><strong><span style='font-size:7.5pt;font-family:Verdana'>Q: What are 1313 the challenges to development of medical <span class=SpellE>nanorobots</span>?</span></strong><span 1314 style='font-size:7.5pt;font-family:Verdana'><o:p></o:p></span></p> 1315 <p><span class=SpellE><span style='font-size:7.5pt;font-family:Verdana'>Cavalcanti</span></span><span 1316 style='font-size:7.5pt;font-family:Verdana'>: The main challenge is the 1317 need to a method for building complex devices to molecular precision. This 1318 is easiest in the biological realm, where biological <span class=SpellE>nanorobots</span> 1319 using genetic cassettes inserted into minimalist <span class=SpellE>microorganisms</span> 1320 (~250 genes) are already in fast development using the methods of synthetic 1321 biology.<o:p></o:p></span></p> 1322 <p><span style='font-size:7.5pt;font-family:Verdana'>More complex and 1323 capable medical <span class=SpellE>nanorobots</span> (www.nanomedicine.com) 1324 fabricated from <span class=SpellE>diamondoid</span> or other similarly 1325 rigid materials await mainly our ability to do positional <span 1326 class=SpellE>mechanosynthesis</span>. Diamond <span class=SpellE>mechanosynthesis</span> 1327 has been shown to be feasible in numerous recently published papers and 1328 books (foresight.org/stage2/mechsynthbib.html). There are theoretical 1329 proposals to create the first experimental tools for diamond <span 1330 class=SpellE>mechanosynthesis</span>, and <span class=SpellE>mechanosynthesis</span> 1331 using individual silicon atoms has already been demonstrated 1332 experimentally.<o:p></o:p></span></p> 1333 <p><strong><span style='font-size:7.5pt;font-family:Verdana'>Q: You have 1334 suggested the first applications will be available in 10 years’ time. 1335 Why is this a realistic timetable?</span></strong><span style='font-size: 1336 7.5pt;font-family:Verdana'><o:p></o:p></span></p> 1337 <p><span class=SpellE><span style='font-size:7.5pt;font-family:Verdana'>Cavalcanti</span></span><span 1338 style='font-size:7.5pt;font-family:Verdana'>: Developments in the field of <span 1339 class=SpellE>biomolecular</span> computing have demonstrated the 1340 feasibility of processing logic tasks by <span class=SpellE>biocomputers</span>, 1341 a promising first step toward building future <span class=SpellE>nanoprocessors</span> 1342 with increasing complexity. There has been progress in building biosensors 1343 and <span class=SpellE>nanokinetic</span> devices, which also may be 1344 required to enable <span class=SpellE>nanorobots</span>’ operations 1345 and locomotion. Classical objections related to the feasibility of 1346 nanotechnology have been considered and resolved, and discussions of 1347 techniques for manufacturing <span class=SpellE>nanodevices</span> are 1348 appearing in the literature with increasing frequency.<o:p></o:p></span></p> 1349 <p><span style='font-size:7.5pt;font-family:Verdana'>Actually, the 1350 manufacturing of <span class=SpellE>nanotransistors</span> and <span 1351 class=SpellE>nanodevices</span> is being pursued gradually with remarkable 1352 successes. For example, by 2016 high-performance integrated circuits (ICs) 1353 will contain more than 8.8 billion transistors in a 280 mm area -- more 1354 than 25 times as many as on today’s chips built with 130 nm feature 1355 sizes. <o:p></o:p></span></p> 1356 <p><span style='font-size:7.5pt;font-family:Verdana'>At the present rate of 1357 progress, the first biological <span class=SpellE>nanorobots</span> should 1358 be available within five years or less. More sophisticated <span 1359 class=SpellE>nanorobots</span> will naturally appear through the 1360 development of <span class=SpellE>diamondoid</span> <span class=SpellE>mechanosynthesis</span> 1361 and structures. It will also be at least five years until diamond <span 1362 class=SpellE>mechanosynthesis</span> can be demonstrated in the lab, and at
1363 least five years after before any significant <span class=SpellE>diamondoid</span> 1364 structures can be built to specifications. In both cases, we will need 1365 proven control methodologies to be available. We can best prepare by doing 1366 simulations today.<o:p></o:p></span></p> 1367 <p><strong><span style='font-size:7.5pt;font-family:Verdana'>Q: You have a 1368 paper in preparation on design of <span class=SpellE>nanorobot</span> 1369 control simulation for stem cell manipulation. Can you tell us about this 1370 work?</span></strong><span style='font-size:7.5pt;font-family:Verdana'><o:p></o:p></span></p> 1371 <p><span class=SpellE><span style='font-size:7.5pt;font-family:Verdana'>Cavalcanti</span></span><span 1372 style='font-size:7.5pt;font-family:Verdana'>: We have a set of works in 1373 development for stem cells. The first announced work is to get an overview 1374 of possible approaches to using <span class=SpellE>nanorobots</span> to 1375 recognize and capture bone-marrow stem cells for medical applications. The 1376 second work announced recently is an applied study, where <span 1377 class=SpellE>nanorobots</span> inject bone marrow stem cells to treat 1378 diabetes. Nowadays we may see stem cells and <span class=SpellE>nanorobots</span> 1379 as one of the most intriguing fields of research, where the going advances 1380 in both fields together have a spectacular synergetic impact on our future 1381 life span. <o:p></o:p></span></p> 1382 <p><strong><span style='font-size:7.5pt;font-family:Verdana'>Q: Do you have 1383 any plans to commercialize your work?</span></strong><span 1384 style='font-size:7.5pt;font-family:Verdana'><o:p></o:p></span></p> 1385 <p><span class=SpellE><span style='font-size:7.5pt;font-family:Verdana'>Cavalcanti</span></span><span 1386 style='font-size:7.5pt;font-family:Verdana'>: Considering the importance of 1387 <span class=SpellE>nanorobot</span> control, design and manufacturing, and 1388 observing the possible applications that <span class=SpellE>nanorobots</span> 1389 face, we plan to commercialize the system. Probably a first trial version 1390 could be included in one of the books that we are preparing. After that, we 1391 have also a project to disclose a more detailed NCD version with a module 1392 that could permit users to define specific parameters and load 3D models 1393 easily and more friendly.<o:p></o:p></span></p> 1394 <p><span style='font-size:7.5pt;font-family:Verdana'>As a research 1395 scientist, the plan is gradually to open a research <span class=SpellE>center</span> 1396 that could enable a growing technical international network exchange with 1397 private companies, research institutes and universities. This could be a 1398 practical way to enable investors to <span class=SpellE>participatein</span> 1399 the development of commercial <span class=SpellE>nanobiotechnology</span> 1400 systems and devices that may benefit people around the globe with 1401 biomedical engineering advances.<o:p></o:p></span></p> 1402 <p><strong><span style='font-size:7.5pt;font-family:Verdana'>Q: What is 1403 your next step?</span></strong><span style='font-size:7.5pt;font-family: 1404 Verdana'><o:p></o:p></span></p> 1405 <p><span class=SpellE><span style='font-size:7.5pt;font-family:Verdana'>Cavalcanti</span></span><span 1406 style='font-size:7.5pt;font-family:Verdana'>: A keen observer could 1407 visualize with reasonable <span class=SpellE>acurity</span> that our 1408 society lives in a remarkable age, where bridges for the future are being 1409 constructed and pursued step by step. Today we can produce knowledge and 1410 technical advances in unbelievable speed, enabled by the actual computers 1411 as ancillary facilities. In this scenery, <span class=SpellE>nanobiotechnology</span> 1412 and robotics could be viewed as breakthroughs for the very near revolution 1413 that we are going to produce in human history.<o:p></o:p></span></p> 1414 <p><span style='font-size:7.5pt;font-family:Verdana'>My aim is to keep 1415 working on implementation of new concepts and investigation of control and 1416 design of <span class=SpellE>nanorobots</span>, focusing on the fast 1417 development of nanotechnology with its applications in medicine and biotechnology. 1418 The next possible steps could be the joint investigation of <sp
1418an 1419 class=SpellE>nanorobots</span> and <span class=SpellE>nanoelectronics</span>. 1420 With coming important technological developments, their link is very 1421 interesting -- it is possible that <span class=SpellE>nanorobots</span> 1422 could be composed by <span class=SpellE>nanolectronics</span> as well as 1423 that <span class=SpellE>nanoelectronics</span> and devices could be 1424 manufactured by <span class=SpellE>nanorobots</span>.<o:p></o:p></span></p> 1425 <p><span style='font-size:7.5pt;font-family:Verdana'>We have a set of 1426 projects and works on the way. For example, we are making extensive 1427 investigations into <span class=SpellE>nanorobot</span> designs, such as 1428 motion strategies for low energy consumption, <span class=SpellE>nanorobot</span> 1429 decentralized control techniques, and collective <span class=SpellE>behavior</span> 1430 design in face of biomedical parameters for specific cases, just to quote a 1431 few.<o:p></o:p></span></p> 1432 <p><span style='font-size:7.5pt;font-family:Verdana'> <o:p></o:p></span></p> 1433 <p><span style='font-size:7.5pt;font-family:Verdana'>Contact Adriano <span 1434 class=SpellE>Cavalcanti</span> at
1434<script language="JavaScript" type="text/javascript"> 1435 1436<!-- 1437var prefix = 'ma' + 'il' + 'to'; 1438var path = 'hr' + 'ef' + '='; 1439var addy80566 = 'adrianocavalcanti' + '@'; 1440addy80566 = addy80566 + 'ieee' + '.' + 'org'; 1441var addy_text80566 = 'adrianocavalcanti' + '@' + 'ieee' + '.' + 'org'; 1442document.write( '<a ' + path + '\'' + prefix + ':' + addy80566 + '\'>' ); 1443document.write( addy_text80566 ); 1444document.write( '<\/a>' ); 1445//--> 1446 </script>
1446<span style='mso-spacerun:yes'> </span>This email address is being 1447 protected from spam bots, you need Javascript enabled to view it </noscript>.<o:p></o:p></span></p> 1448 <p><span style='font-size:7.5pt;font-family:Verdana'>Reprinted with 1449 permission from <span class=SpellE>NanoBiotech</span> News, published by 1450 NHI Publications, <st1:place w:st="on"><st1:City w:st="on">Atlanta</st1:City>, 1451 <st1:State w:st="on">GA.</st1:State></st1:place> Copyright © 2004. 1452 Original text available at:<span style='mso-spacerun:yes'> </span><b><span 1453 style='border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm; 1454 padding:0cm'><a 1455 href="http://www.nanorobotdesign.com/article/nanobiotech.pdf">www.nanorobotdesign.com/article/nanobiotech.pdf</a> 1456 </span></b><o:p></o:p></span></p> 1457 <p><span style='font-size:7.5pt;font-family:Verdana'>All rights reserved. 1458 For subscription information call (800) 597-6300.<o:p></o:p></span></p> 1459 </td> 1460 </tr> 1461 </table> 1462 <p class=MsoNormal style='line-height:13.5pt'><span class=articleseperator><span 1463 style='font-size:7.5pt;font-family:Verdana'> </span></span><span 1464 style='font-size:7.5pt;font-family:Verdana'> <o:p></o:p></span></p> 1465 <div> 1466 <p class=MsoNormal style='line-height:13.5pt'><span style='font-size:7.5pt; 1467 font-family:Verdana'><a href="javascript:history.go(-1)"><span 1468 style='mso-ansi-font-weight:normal;mso-bidi-font-weight:normal'>[ Back ] </span></a><o:p></o:p></span></p> 1469 </div> 1470 </div> 1471 <div id=user5> 1472 <div style='border:solid #EFEFEF 1.0pt;mso-border-alt:solid #EFEFEF .75pt; 1473 padding:0cm 0cm 0cm 0cm;margin-bottom:7.5pt'> 1474 <div style='mso-element:para-border-div;border:none;border-bottom:solid #EFEFEF 1.0pt; 1475 mso-border-bottom-alt:solid #EFEFEF .75pt;padding:0cm 0cm 0cm 0cm'> 1476 <p class=MsoNormal style='text-indent:3.75pt;line-height:15.0pt;mso-outline-level: 1477 4;border:none;mso-border-bottom-alt:solid #EFEFEF .75pt;padding:0cm; 1478 mso-padding-alt:0cm 0cm 0cm 0cm'><b><span style='font-size:9.0pt;font-family: 1479 Verdana;color:white'>Latest News <o:p></o:p></span></b></p> 1480 </div> 1481 <p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto; 1482 margin-left:8.4pt;text-indent:-18.0pt;mso-list:l1 level1 lfo4;tab-stops:list 36.0pt'><![if !supportLists]><span 1483 style='font-size:10.0pt;mso-bidi-font-size:7.5pt;font-family:Wingdings; 1484 mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span 1485 style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'> 1486 </span></span></span><![endif]><span style='font-size:7.5pt;font-family:Verdana'><a 1487 href="http://www.merlinq.nl/index.php?option=com_content&task=view&id=316&Itemid=74"><b>Engineers 1488 creating small wireless device to improve cancer treatment</b></a> <o:p></o:p></span></p> 1489 <p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto; 1490 margin-left:8.4pt;text-indent:-18.0pt;mso-list:l1 level1 lfo4;tab-stops:list 36.0pt'><![if !supportLists]><span 1491 style='font-size:10.0pt;mso-bidi-font-size:7.5pt;font-family:Wingdings; 1492 mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span 1493 style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'> 1494 </span></span></span><![endif]><span style='font-size:7.5pt;font-family:Verdana'><a 1495 href="http://www.merlinq.nl/index.php?option=com_content&task=view&id=255&Itemid=73"><b>International 1496 Public Policy Archive</b></a> <o:p></o:p></span></p> 1497 <p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto; 1498 margin-left:8.4pt;text-indent:-18.0pt;mso-list:l1 level1 lfo4;tab-stops:list 36.0pt'><![if !supportLists]><span 1499 style='font-size:10.0pt;mso-bidi-font-size:7.5pt;font-family:Wingdings; 1500 mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span 1501 style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'> 1502 </span></span></span><![endif]><span style='font-size:7.5pt;font-family:Verdana'><a 1503 href="http://www.merlinq.nl/index.php?option=com_content&task=view&id=254&Itemid=73"><b>Nanotech 1504 Wonder Water?</b></a> <o:p></o:p></span></p> 1505 <p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto; 1506 margin-left:8.4pt;text-indent:-18.0pt;mso-list:l1 level1 lfo4;tab-stops:list 36.0pt'><![if !supportLists]><span 1507 style='font-size:10.0pt;mso-bidi-font-size:7.5pt;font-family:Wingdings; 1508 mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span 1509 style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'> 1510 </span></span></span><![endif]><span style='font-size:7.5pt;font-family:Verdana'><a 1511 href="http://www.merlinq.nl/index.php?option=com_content&task=view&id=240&Itemid=74"><b>Purdue 1512 engineers solve chaos mystery in use of high-tech microscope</b></a> <o:p></o:p></span></p> 1513 <p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto; 1514 margin-left:8.4pt;text-indent:-18.0pt;mso-list:l1 level1 lfo4;tab-stops:list 36.0pt'><![if !supportLists]><span 1515 style='font-size:10.0pt;mso-bidi-font-size:7.5pt;font-family:Wingdings; 1516 mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings'><span 1517 style='mso-list:Ignore'>§<span style='font:7.0pt "Times New Roman"'> 1518 </span></span></span><![endif]><span style='font-size:7.5pt;font-family:Verdana'><a 1519 href="http://www.merlinq.nl/index.php?option=com_content&task=view&id=239&Itemid=74"><b>Anti-Adhesive 1520 Layers Leave No Hope for Insects</b></a> <o:p></o:p></span></p> 1521 </div> 1522 <div style='border:solid #EFEFEF 1.0pt;mso-border-alt:solid #EFEFEF .75pt; 1523 padding:0cm 0cm 0cm 0cm;margin-bottom:7.5pt'> 1524 <div style='mso-element:para-border-div;border:none;border-bottom:solid #EFEFEF 1.0pt; 1525 mso-border-bottom-alt:solid #EFEFEF .75pt;padding:0cm 0cm 0cm 0cm'> 1526 <p class=MsoNormal style='text-indent:3.75pt;line-height:15.0pt;mso-outline-level: 1527 4;border:none;mso-border-bottom-alt:solid #EFEFEF .75pt;padding:0cm; 1528 mso-padding-alt:0cm 0cm 0cm 0cm'><b><span style='font-size:9.0pt;font-family: 1529 Verdana;color:white'>Latest Events <o:p></o:p></span></b></p> 1530 </div> 1531 </div> 1532 </div> 1533 </div> 1534 </td> 1535 </tr> 1536</table> 1537 1538<p class=MsoNormal><o:p> </o:p></p> 1539 1540</div> 1541 1542</div> 1543 1544</div> 1545 1546</body> 1547 1548</html>
Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.